Shanghai Cell Therapy Group

Provider of cell-therapy focused research and development services

placeShanghai, Shanghai, China calendar_todayFounded 2014 groups70 employees language shcell.com

Innovation

171 patent families (21 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 1,140 times.

YearFilings
20181
201932
202033
202116
202211
202316
202427
202553
20269

Investor mix

9 investors on record; lead investors include Jiuzhou Venture Capital, CCB International, Haier Capital, Shanghai Shengshi Capital Management.

Investor typeCountShare
Venture capital444%
Private equity222%
Bank & private debt111%
Other / undisclosed222%
Coming soon